Detecting Carcinoma Cells in Blood Using RT-PCR
Author Information
Author(s): W Helfrich, R ten Poele, GJ Meersma, NH Mulder, EGE de Vries, L de Leij, EF Smit
Primary Institution: University Hospital Groningen
Hypothesis
The presence of carcinoma cells in peripheral blood can predict disease recurrence and metastasis.
Conclusion
A sensitive quantitative RT-PCR assay was developed to detect carcinoma cells in peripheral blood, which may help in predicting disease recurrence.
Supporting Evidence
- The assay can detect as few as ten carcinoma cells among 1.0 x 10^6 leukocytes.
- Normal bone marrow expresses low levels of EGP2 mRNA.
- EGP2 is a pancarcinoma-associated glycoprotein expressed in many carcinomas.
Takeaway
Scientists created a test to find cancer cells in blood, which can help doctors know if a patient might get sick again.
Methodology
The study used a quantitative RT-PCR assay to detect EGP-2 mRNA in blood and bone marrow samples.
Limitations
The assay may detect illegitimate transcription of EGP2 in normal cells, complicating the interpretation of results.
Participant Demographics
Seven healthy volunteers provided blood samples.
Want to read the original?
Access the complete publication on the publisher's website